No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples